Compounds > n-(2-aminoethyl)-5-isoquinolinesulfonamide
Page last updated: 2024-10-28

n-(2-aminoethyl)-5-isoquinolinesulfonamide and Glioma

n-(2-aminoethyl)-5-isoquinolinesulfonamide has been researched along with Glioma in 1 studies

Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Muñoz-Fernández, MA1
Fresno, M1

Other Studies

1 other study available for n-(2-aminoethyl)-5-isoquinolinesulfonamide and Glioma

ArticleYear
Involvement of nitric oxide on the cytokine induced growth of glial cell.
    Biochemical and biophysical research communications, 1993, Jul-15, Volume: 194, Issue:1

    Topics: Animals; Arginine; Cell Division; Cytokines; Glioma; Humans; Interferon-gamma; Interleukin-6; Isoqui

1993